(VIANEWS) – TriplePoint Venture Growth BDC Corp. (TPVG), John Hancock (HPS), Novo Nordisk A/S (NVO) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. TriplePoint Venture Growth BDC Corp. (TPVG)

101.41% Payout Ratio

TriplePoint Venture Growth BDC Corp, a business development firm that specializes in investments at the growth stage, is TriplePoint Venture Growth BDC Corp. The company also offers debt financing for venture growth companies, including equipment financings and growth capital loans. It invests in the e-commerce and entertainment sectors as well as technology and life science. Technology includes security, wireless communication, system software, business application software, conferencing softwares/services. Life sciences include biotechnology, biofuels/bio mass and diagnostic testing. Drug delivery, drug discovery and healthcare information systems. It invests in growth capital loans between $5m and $50m, equipment financings from $5m to $25m, revolving loans between $1m and $25m, direct equity investments between $0.1m and $5m (generally, not exceeding 5%). It invests in secured and warranted loans and lines of credit. The company does not have a board member.

Volume

Today’s last reported volume for TriplePoint Venture Growth BDC Corp. is 204049, 23.47% below its average volume of 266656.

As stated by Morningstar, Inc., the next dividend payment is on Sep 13, 2022, the estimated forward annual dividend rate is 1.44 and the estimated forward annual dividend yield is 10.83%.

TriplePoint Venture Growth BDC Corp.’s sales growth this year is anticipated to be 28% and 8.1% for next year.

Year-on-year quarterly revenue growth grew by 35.1%, now sitting on 101.2M for the twelve trailing months.

TriplePoint Venture Growth BDC Corp.’s sales growth is 27.5% for the ongoing quarter and 12.8% for the next. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.9%.

Volatility

TriplePoint Venture Growth BDC Corp.’s last day, week, and month’s current intraday variation average was 0.30%, 0.60%, and 1.52%, respectively.

TriplePoint Venture Growth BDC Corp.’s highest amplitude of average volatility was 1.34% (day), 1.50% (last week), and 2.17% (last month), respectively.

TriplePoint Venture Growth BDC Corp.’s Stock Yearly Top and Bottom Value

TriplePoint Venture Growth BDC Corp.’s stock is valued at $13.47 at 14:23 EST, way under its 52-week high of $19.25 and way higher than its 52-week low of $11.86.

TriplePoint Venture Growth BDC Corp.’s Moving Average

TriplePoint Venture Growth BDC Corp.’s worth is higher than its 50-day moving average of $13.29 and way below its 200-day moving average of $15.83.

2. John Hancock (HPS)

88.59% Payout Ratio

John Hancock Preferred Income Fund III, a closed-ended fixed income mutual fund that was launched by John Hancock Investment Management LLC. John Hancock Asset Management co-manages the fund. It invests in fixed income markets within the United States. The fund seeks investments in securities from companies that operate across multiple sectors. It invests primarily in fixed-income preferred securities and other fixed income securities rated investment quality or higher by Standard & Poor’s. The fund benchmarks its performance against both the Bank of America Merrill Lynch Hybrid Preferred Securities Index (Barclays U.S. Aggregate Bond Index. John Hancock Preferred Income Fund III, which was established June 19, 2003, is based in the United States.

Volume

Today’s last reported volume for John Hancock is 13194, 69.2% below its average volume of 42840.

As maintained by Morningstar, Inc., the next dividend payment is on Aug 9, 2022, the estimated forward annual dividend rate is 1.32 and the estimated forward annual dividend yield is 8.11%.

Year-on-year quarterly revenue growth declined by 4%, now sitting on 48.36M for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.95%.

Volatility

John Hancock’s last day, week, and month’s current intraday variation average was 0.06%, 0.78%, and 0.73%, respectively.

John Hancock’s highest amplitude of average volatility was 1.42% (day), 1.57% (last week), and 1.38% (last month), respectively.

John Hancock’s Stock Yearly Top and Bottom Value

John Hancock’s stock is valued at $16.20 at 14:24 EST, way below its 52-week high of $19.89 and higher than its 52-week low of $14.96.

John Hancock’s Moving Average

John Hancock’s value is under its 50-day moving average of $16.25 and below its 200-day moving average of $17.29.

3. Novo Nordisk A/S (NVO)

47.8% Payout Ratio

Novo Nordisk A/S is a global healthcare company that specializes in research, development and manufacture of pharmaceutical products. The company operates in two areas: Diabetes and Obesity Care and Biopharm. Diabetes and Obesity Care provides products for insulins, GLP-1, related delivery systems and oral anti-inflammatory products. Biopharmaceuticals offers products that address haemophilia and growth disorders as well as hormone replacement therapy. To explore new delivery strategies, Novo Nordisk A/S has entered into research agreements with Lumen Bioscience, Inc. and Gilead Sciences, Inc. It was established in Denmark in 1923. The headquarters are located in Bagsvaerd.

Volume

Today’s last reported volume for Novo Nordisk A/S is 3145630, 92.32% above its average volume of 1635600.

As claimed by Morningstar, Inc., the next dividend payment is on Mar 24, 2022, the estimated forward annual dividend rate is 1.57 and the estimated forward annual dividend yield is 1.36%.

Novo Nordisk A/S’s sales growth this year is expected to be 13.7% and 11.2% for next year.

Year-on-year quarterly revenue growth grew by 24.3%, now sitting on 149.03B for the twelve trailing months.

Novo Nordisk A/S’s sales growth for the next quarter is 13.9%. The company’s growth estimates for the next quarter is 1.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 78.92%.

Volatility

Novo Nordisk A/S’s last day, week, and month’s current intraday variation average was 2.69%, 1.64%, and 1.53%, respectively.

Novo Nordisk A/S’s highest amplitude of average volatility was 1.60% (day), 1.80% (last week), and 1.96% (last month), respectively.

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $101.76 at 14:24 EST, way below its 52-week high of $122.16 and way higher than its 52-week low of $91.51.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s worth is below its 50-day moving average of $109.13 and below its 200-day moving average of $107.83.

4. Fresenius Medical Care AG (FMS)

44.81% Payout Ratio

Fresenius Medical Care AG & Co. KGaA offers dialysis services and other related care in Germany, North America and abroad. Fresenius Medical Care AG & Co. KGaA provides dialysis care and associated laboratory and diagnostic services via a network of dialysis clinics. It also produces, distributes and manufactures dialysis products. These include hemodialysis machine, dialysis solution, dialysis cycles, dialysis concentrates and solutions, dialysis systems, bloodlines and renal pharmaceuticals. It also develops, acquires and in-licenses kidney pharmaceuticals. The company offers supplies and medications to renal patients at home or in dialysis clinics. It sells products directly to hospitals and dialysis centers, as well through independent distributors and dealers and local agents. It had 4,171 dialysis clinics operating in around 150 countries as of February 23rd 2022. Fresenius Medical Care AG & Co. KGaA is a German company that was founded in 1996. Its headquarters are in Bad Homburg.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 510675, 45.52% below its average volume of 937477.

As stated by Morningstar, Inc., the next dividend payment is on May 12, 2022, the estimated forward annual dividend rate is 0.71 and the estimated forward annual dividend yield is 3.83%.

Fresenius Medical Care AG’s sales growth this year is expected to be 4.3% and 5.3% for next year.

Year-on-year quarterly revenue growth grew by 8%, now sitting on 17.96B for the twelve trailing months.

Fresenius Medical Care AG’s sales growth is negative 11.9% for the present quarter and negative 9.1% for the next. The company’s growth estimates for the next quarter is negative 5.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.12%.

Volatility

Fresenius Medical Care AG’s last day, week, and month’s current intraday variation average was 3.07%, 3.26%, and 1.66%, respectively.

Fresenius Medical Care AG’s highest amplitude of average volatility was 1.87% (day), 2.12% (last week), and 2.21% (last month), respectively.

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $16.74 at 14:24 EST, way below its 52-week high of $36.95 and higher than its 52-week low of $16.06.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s value is way below its 50-day moving average of $20.05 and way below its 200-day moving average of $28.54.

5. Ames National Corporation (ATLO)

44.68% Payout Ratio

Ames National Corporation is a multibank holding company. It provides services and products in central and north-central Iowa’s Polk, Marshall and Story counties. It accepts deposits of all types, including savings and checking accounts, as well as time deposits such money market accounts or certificates of deposit. The company also offers loans such as loans to short-term, medium-term, commercial, agricultural, or residential real estate. It can also provide loans for equipment, vehicles, home improvements, personal loans, lines of credit, lines of credit, lines of credit, lines of credit, loans for agricultural, business, and other purposes. The company also offers merchant credit card processing and cash management. It can wire transfer and deposit payroll, secure deposit boxes, equipment, vehicle, and home improvement loans. Additionally, it provides automated/video-teller machine access and drafts to various accounts. It also offers investment and farm management services as well as custodial and custodial services to individuals, non-profit organisations, businesses and small business owners. Ames National Corporation was established in 1903, and it is located in Ames.

Volume

Today’s last reported volume for Ames National Corporation is 6672, 58.28% below its average volume of 15995.

As stated by Morningstar, Inc., the next dividend payment is on Oct 30, 2022, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 4.86%.

Year-on-year quarterly revenue growth declined by 4.5%, now sitting on 65.13M for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.62%.

Volatility

Ames National Corporation’s last day, week, and month’s current intraday variation average was 0.27%, 0.41%, and 0.37%, respectively.

Ames National Corporation’s highest amplitude of average volatility was 0.91% (day), 1.16% (last week), and 1.50% (last month), respectively.

Ames National Corporation’s Stock Yearly Top and Bottom Value

Ames National Corporation’s stock is valued at $22.04 at 14:24 EST, way below its 52-week high of $25.55 and above its 52-week low of $21.81.

Ames National Corporation’s Moving Average

Ames National Corporation’s worth is under its 50-day moving average of $22.21 and under its 200-day moving average of $23.63.